SCHEMBL4983200

SCHEMBL4983200

CCN(CC)CCNC(=O)N(S)c1ccc2c(c1)Cc1cc(Br)ccc1-2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
MCHR1 Q99705 1/20 0.37
FPR3 P25089 1/20 0.37
FPR2 P25090 1/20 0.37
KMT2A Q03164 2/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
PDGFRB P09619 2/20 0.35
KDR P35968 2/20 0.35
EGFR P00533 1/20 0.35
FGFR1 P11362 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979553 0.89 CYP1A2 (0.44) LMNAFPR3FPR2KMT2ASLC1A3
SCHEMBL4979173 0.89 NAMPT (0.40) LMNAL3MBTL1SLC1A3SLC1A2SLC1A1
SCHEMBL4979942 0.87 MGLL (0.38) LMNAKMT2ASLC1A3SLC1A2SLC1A1
SCHEMBL4980233 0.86 SLC1A3 (0.40) KMT2ASLC1A3SLC1A2SLC1A1TSHR
SCHEMBL3982025 0.86 MGLL (0.42) LMNAFPR3FPR2KMT2ASLC1A3
SCHEMBL4979475 0.86 MGLL (0.42) LMNAFPR3FPR2KMT2ASLC1A3
SCHEMBL4984400 0.86 MGLL (0.42) LMNAFPR3FPR2KMT2ASLC1A3
SCHEMBL3977113 0.86 MGLL (0.42) LMNAFPR3FPR2KMT2ASLC1A3
SCHEMBL4980970 0.85 KDM4E (0.46) L3MBTL1FPR3FPR2SLC1A3SLC1A2
SCHEMBL4980961 0.82 LMNA (0.42) LMNAFPR3FPR2KMT2ASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 LMNA 4873/4885L3MBTL1 822/4885PRKAA2 4286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.